TrialArthritis research & therapy2025

Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study.

Jae-Bum Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.